{
  "documents": [
    {
      "id": "cluster_4_doc1",
      "content": "Advanced Rehab Solutions submitted a prior authorization request for patient LK-2098 (DOB 05/12/1974) for intensive neurocognitive therapy following a prion disease diagnosis. The treatment plan includes 12 weeks of specialized cognitive rehabilitation at Sandpiper Neurocare Center in Venice, FL. Supporting documentation highlights abnormal protein buildup confirmed via CSF analysis on 03/15/2024.",
      "metadata": {
        "format": "provider_report"
      }
    },
    {
      "id": "cluster_4_doc2",
      "content": "Suncoast Health Partners policy memo 4892-RV updates coverage guidelines for rare neurological conditions effective June 2024. Requires dual specialist approval for prion disease therapies exceeding $50,000 annually. Exceptions permitted for patients enrolled in the Coastal Neuro Registry study (ID# CNN-4888) at participating Florida facilities.",
      "metadata": {
        "format": "policy_document"
      }
    },
    {
      "id": "cluster_4_doc3",
      "content": "Venice Daily Tribune healthcare section reports Sandpiper Neurocare launching new prion disease research initiative with $2.1M grant. Study coordinator Dr. Emilia Vasquez notes enrollment priority for patients like LK-2098 receiving concurrent rehabilitation. Program includes genetic marker analysis and longitudinal outcome tracking through 2026.",
      "metadata": {
        "format": "news_article"
      }
    },
    {
      "id": "cluster_4_doc4",
      "content": "Claim #48824-CC for patient LK-2098 was partially denied due to missing documentation per updated policy 4892-RV. Requires neuropsychologist progress reports every 4 weeks and updated treatment justification from both Dr. Vasquez and primary neurologist. Appeal must be submitted by 07/01/2024 to maintain coverage continuity.",
      "metadata": {
        "format": "insurance_memo"
      }
    },
    {
      "id": "cluster_4_doc5",
      "content": "Patient satisfaction survey from LK-2098 mentions excellent coordination between Advanced Rehab Solutions and Sandpiper Neurocare, but expresses frustration with insurance delays. Notes frequent communication with case manager Linh Tran (ext. 224) about appeal process. Survey received 04/28/2024 with 4/5 overall rating.",
      "metadata": {
        "format": "patient_survey"
      }
    }
  ],
  "metadata": {
    "category": "cluster",
    "cluster_id": "cluster_4",
    "cluster_risk": "HIGH",
    "content_summary": "Comprehensive case involving prion disease treatment, policy updates, and research enrollment in Florida neurocare facility",
    "person": {
      "entities": [
        [
          "LK-2098",
          "PATIENT_ID"
        ],
        [
          "05/12/1974",
          "BIRTHDATE"
        ],
        [
          "prion disease",
          "MEDICAL_CONDITION"
        ],
        [
          "Sandpiper Neurocare Center",
          "LOCATION"
        ],
        [
          "Venice, FL",
          "LOCATION"
        ],
        [
          "03/15/2024",
          "EVENT_DATE"
        ],
        [
          "CNN-",
          "NON_PERSONAL_ID"
        ],
        [
          "Coastal Neuro Registry",
          "UNIQUE_FACT"
        ],
        [
          "Lin Tran",
          "NAME"
        ],
        [
          "48824-CC",
          "NON_PERSONAL_ID"
        ],
        [
          "07/01/2024",
          "EVENT_DATE"
        ],
        [
          "04/28/2024",
          "EVENT_DATE"
        ],
        [
          "advanced neurocognitive therapy",
          "TREATMENT"
        ]
      ]
    },
    "questions": [
      {
        "q": "What two documentation requirements caused the partial denial of claim 48824-CC for patient LK-2098's prion disease treatment?",
        "a": "Neuropsychologist progress reports every 4 weeks and updated treatment justification from both specialists.",
        "sources": [
          "cluster_4_doc4"
        ],
        "type": "specific"
      },
      {
        "q": "What new rare neurological condition policy requires dual specialist approval for expensive therapies?",
        "a": "Suncoast Health Partners policy 4892-RV effective June 2024.",
        "sources": [
          "cluster_4_doc2"
        ],
        "type": "general"
      },
      {
        "q": "Which research program and care facility involve patient LK-2098's concurrent prion disease treatment?",
        "a": "Coastal Neuro Registry study CNN-4888 at Sandpiper Neurocare Center.",
        "sources": [
          "cluster_4_doc1",
          "cluster_4_doc2"
        ],
        "type": "specific"
      },
      {
        "q": "What treatment duration was specified for patient LK-2098 in the prior authorization request, and what overall rating did the patient give in the April 2024 survey?",
        "a": "12 weeks; 4/5 rating.",
        "sources": [
          "cluster_4_doc1",
          "cluster_4_doc5"
        ],
        "type": "general"
      }
    ]
  }
}